Concepedia

Publication | Open Access

Canakinumab in adults with steroid‐refractory pyoderma gangrenosum

108

Citations

23

References

2015

Year

Abstract

Our data indicate that IL-1β plays a key pathogenic role in PG and canakinumab may represent a therapeutic option for steroid-refractory PG.

References

YearCitations

Page 1